2022 Rosenman Innovators
Meet the talented healthtech founders joining our wonderful community.
Aila Health is a virtual care company supporting the 50M Americans living with autoimmune disease with integrative, multispecialty care and remote monitoring tools.
ATDev is building the future of assistive technology. Their product, Rehab Robo, redefines the standard of care for post surgical physical therapy by combining exoskeleton technology with the telehealth experience.
Corveus is creating a catheter that ablates the splanchnic nerve to prevent heart failure. Their device can uniquely access this nerve that was previously only accessible during surgery.
Efemoral Medical is a clinical stage start-up developing a novel bioresorbable drug-eluting scaffold specifically designed to treat peripheral arterial disease, a condition that afflicts over 200 million people worldwide.
Intellihealth’s Evolve platform is a turnkey solution that easily integrates into the existing health care ecosystem to streamline all aspects of medical obesity care, including assessment, diagnosis, prescription and treatment.
A cloud-based digital healthcare platform with optimized clinical trial recruitment and retention of underrepresented participants along with new site locations services.
The Lumi Health AI-driven Intelligent Care Platform focuses physicians on the most urgent and important medication improvement opportunities for Heart Failure patients. Lumi Health does this 100x faster than it’s done today.
NeuraStasis is developing the AED for stroke – a noninvasive neurostimulation device that presses pause on stroke progression to give providers more time to intervene.
Neurovalens makes non-invasive technology that treats type 2 diabetes by stimulating the area of the brainstem that regulates glucose. Phase III trials are scheduled to finish in late 2022.
FlowSense, is a wireless and noninvasive flow sensor that can be mounted on skin overlying the shunt to detect the magnitude of fluid flow through shunts in patients with hydrocephalus.
FDA Breakthrough device designation for fibromyalgia (class II), Sana is an audiovisual neuromodulation device that gives anxiety relief on demand, giving it applications across pain, mental health, and long covid.